To elucidate the mechanistic basis of leukotriene inhibition in ARDS, we focused on two key effectors of neutrophil function: the ERK1/2 branch of MAP kinase signaling and the surface expression of adhesion molecules. The gene discussed is MAPK3; the disease is acute respiratory distress syndrome.